
Revolution Medicines, Inc.
USD183.29
+2.90 (+1.61%)
CEO
Mark A. Goldsmith
IPO Date
2020-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$181.27
Prev. Close
$180.39
Day Low
$179.39
Day High
$184.25
52W Low
$34.00
52W High
$193.82
Market Cap
$38.97B
Volume
2.30M
| 2 Jul 2026 |
| Wedbush |
| Outperform |
| Outperform |
| maintain |
| 30 Jun 2026 | Truist Securities | Buy | Buy | maintain |
| 29 Jun 2026 | Needham | Buy | Buy | maintain |
| 10 Jun 2026 | Evercore ISI Group | Outperform | Outperform | maintain |
| 2 Jun 2026 | RBC Capital | Outperform | Outperform | maintain |
| 1 Jun 2026 | Oppenheimer | Outperform | Outperform | maintain |
| 1 Jun 2026 | HC Wainwright & Co. | Buy | Buy | maintain |